|1.||Karageorgopoulos, Drosos E: 1 article (09/2011)|
|2.||Vouloumanou, Evridiki K: 1 article (09/2011)|
|3.||Michalopoulos, Argyris: 1 article (09/2011)|
|4.||Falagas, Matthew E: 1 article (09/2011)|
|5.||Rafailidis, Petros I: 1 article (09/2011)|
07/01/1986 - "Thus a single dose of trimethoprim-sulfametrole appears to be an effective treatment regimen for women with chancroid in Kenya."
07/14/1983 - "We conducted a randomized double-blind trial comparing a single dose of trimethoprim-sulfametrole (640 to 3200 mg) with five-day regimens of either trimethoprim-sulfametrole (160 to 800 mg twice daily) or trimethoprim alone (200 mg twice daily) for the treatment of men with chancroid. "
07/01/1986 - "Single-dose therapy with trimethoprim-sulfametrole for chancroid in females."
12/29/1983 - "Therapy of chancroid with trimethoprim-sulfametrole."
07/14/1983 - "We conclude that single-dose trimethoprim-sulfametrole is a highly effective, inexpensive therapy for chancroid in men and may prove to be an important strategy for the control of H. "
09/01/2011 - "Sulfametrole (SMT) combined with TMP could provide a choice for difficult-to-treat infections, particularly when administered intravenously. "
01/01/1981 - "The relationship of these results to the good clinical activity of the combination sulfametrole/trimethoprim in the treatment of infections of bacterial origin in the upper and lower airways is discussed."
02/29/1980 - "Because of the tendency of this metabolite to cumulation, in dialysis patients the compound preparation of trimethoprim and sulfametrol should be used only for trasient treatment of acute infections."
09/05/1975 - "[Experience with a combination of sulfametrol and trimethoprim (Lidaprim) in otorhinilaryngologic infections]."
01/01/1981 - "A report is given on the examination of the levels of sulfametrole and trimethoprim in blood and lung tissue of 29 patients with pulmonary tumours of various origin, who were subjected to a pre-operative treatment with 2 tablets 2 times daily of the sulfametrole-trimethoprim combination Lidaprim for an average period of one week because of concurrent bronchopulmonary infections. "
07/01/1986 - "Women with genital ulcer disease who were culture-positive for Haemophilus ducreyi were treated with a single dose of the drug combination trimethoprim-sulfametrole; the dosage was 640 mg of trimethoprim and 3,200 mg of sulfametrole. "
01/01/1983 - "The TMP-SMZ and TMP-sulfametrole regimens were more effective than sulfadimidine, tetracycline, or single-dose doxycycline in curing ulcers. "
01/01/1983 - "One hundred fifty-one men with genital ulcer disease were assigned randomly to treatment with one of five oral antimicrobial regimens: (1) sulfadimidine (1 g four times daily for seven days); (2) tetracycline (500 mg four times daily for seven days); (3) trimethoprim-sulfamethoxazole (TMP-SMZ; 160 mg of TMP and 800 mg of SMZ twice daily for seven days); (4) doxycycline (300 mg as a single dose); or (5) TMP-sulfametrole (640 mg of TMP and 3,200 mg of sulfametrole once as a single dose). "
|4.||Urinary Tract Infections (Urinary Tract Infection)
|5.||Respiratory Tract Infections (Respiratory Tract Infection)
|3.||Thymidine Monophosphate (TMP)
|4.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|1.||Renal Dialysis (Hemodialysis)